Explore our materials

Filters

Results (5583)

Slideset

HIV

INTEREST 2016

(Abstract) Accumulation of HIV-1 drug resistance after continued virological failure on first-line antiretroviral therapy in adults and children | T.S.Boender

Slideset

HIV

INTEREST 2016

(Abstract) Tenofovir-containing first-line ART favourably reduce inflammation markers compared to thymidine analogue nucleoside reverse-transcriptase inhibitors | S. Kroeze

Slideset

HIV

INTEREST 2016

(Abstract) EDCTP as a model for Europe-Africa partnership on HIV/AIDS research and capacity development: Examples from Cameroon | L.J. Pandya

Slideset

HIV

INTEREST 2016

Trial, post-trial, & demonstration project results for Pre-exposure Prophylaxis (PrEP) | Elizabeth Irungu, MBChB, MPH

Slideset

HIV

INTEREST 2016

(Abstract) Predictors of HIV-testing in South African adolescents: schools-based testing, pregnancy and sexual experience | C. Carty

Stephen Watiti

Slideset

HIV

INTEREST 2016

Debate: Gilead: The Continent of Africa is Ready for HIV Pre-Exposure Prophylaxis (PreP) Implementation | Community Advocate | Stephen Watiti, MD

François Venter

MD, FCP, PhD

Slideset

HIV

INTEREST 2016

Debate: Gilead: The Continent of Africa is Ready for HIV Pre-Exposure Prophylaxis (PreP) Implementation | Speaker for the Opposition | François Venter, MD, FCP, PhD

Slideset

HIV

INTEREST 2016

New evidence on oral and topical PrEP for women: rings, gels, injectables | Nyaradzo Mgodi, MBChB, MMed

Slideset

HIV

INTEREST 2016

Dolutegravir in contributing the 90:90:90 ambition | Tuna Lukiana MD, PhD

Slideset

HIV

INTEREST 2016

Sustaining progress on scale-up of voluntary medical male circumcision (VMMC), including role of devices and early infant male circumcision | Zebedee Mwandi, MD

Slideset

HIV

INTEREST 2016

(Abstract) Factors associated with virologic failure in HIV infected individuals in Mansa district, Zambia | G. Mutaawe

Slideset

HIV

INTEREST 2016

(Abstract) Immunologic Criteria are Poor Predictors of Virologic Outcomes: Implications for HIV Monitoring in a Large Treatment Program in Nigeria | J. Okuma

Explore our materials

Your Selection Clear All

Topic

Material Type

Event

(Abstract) Accumulation of HIV-1 drug resistance after continued virological failure on first-line antiretroviral therapy in adults and children | T.S.Boender

(Abstract) Tenofovir-containing first-line ART favourably reduce inflammation markers compared to thymidine analogue nucleoside reverse-transcriptase inhibitors | S. Kroeze

(Abstract) EDCTP as a model for Europe-Africa partnership on HIV/AIDS research and capacity development: Examples from Cameroon | L.J. Pandya

Trial, post-trial, & demonstration project results for Pre-exposure Prophylaxis (PrEP) | Elizabeth Irungu, MBChB, MPH

(Abstract) Predictors of HIV-testing in South African adolescents: schools-based testing, pregnancy and sexual experience | C. Carty

Debate: Gilead: The Continent of Africa is Ready for HIV Pre-Exposure Prophylaxis (PreP) Implementation | Community Advocate | Stephen Watiti, MD

Debate: Gilead: The Continent of Africa is Ready for HIV Pre-Exposure Prophylaxis (PreP) Implementation | Speaker for the Opposition | François Venter, MD, FCP, PhD

New evidence on oral and topical PrEP for women: rings, gels, injectables | Nyaradzo Mgodi, MBChB, MMed

Dolutegravir in contributing the 90:90:90 ambition | Tuna Lukiana MD, PhD

Sustaining progress on scale-up of voluntary medical male circumcision (VMMC), including role of devices and early infant male circumcision | Zebedee Mwandi, MD

(Abstract) Factors associated with virologic failure in HIV infected individuals in Mansa district, Zambia | G. Mutaawe

(Abstract) Immunologic Criteria are Poor Predictors of Virologic Outcomes: Implications for HIV Monitoring in a Large Treatment Program in Nigeria | J. Okuma